Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDLI | AZN | AMGN | GILD | VRTX |
| Company | Pdl Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.73 | 189.95 | 366.19 | 136.58 | 523.04 |
| High | 2.78 | 191.17 | 368.10 | 137.70 | 525.81 |
| Low | 2.39 | 188.67 | 363.00 | 134.59 | 517.00 |
| Latest | 2.47 | 190.75 | 366.72 | 135.02 | 514.42 |
| Change | -0.23 | -2.37 | -1.38 | -1.34 | -7.83 |
| % Change | -8.52% | -1.23% | -0.37% | -0.98% | -1.50% |
| Volume | 30,270,700 | 378,881 | 243,469 | 1,328,837 | 173,165 |
| 20-Day Average Volume | 4,709,610 | 1,915,885 | 3,040,511 | 8,581,358 | 1,877,289 |
| Previous Close | 2.70 | 193.12 | 368.10 | 136.36 | 522.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.58 | 184.01 | 354.18 | 126.89 | 478.05 |
| 20-Day Raw Stochastic | 17.78% | 74.55% | 81.02% | 89.66% | 85.35% |
| 20-Day Relative Strength | 46.04 | 54.05 | 60.49 | 58.81 | 69.78 |
| Weighted Alpha | -24.80 | +27.16 | +24.70 | +20.70 | +20.95 |
| Today's Opinion | 64% Sell | 8% Buy | 72% Buy | 8% Sell | 72% Buy |
| Previous Opinion | 40% Sell | 24% Buy | 72% Buy | 16% Sell | 72% Buy |
| Last Month's Opinion | 56% Sell | 8% Sell | 24% Buy | 24% Sell | Hold |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 12/22/20 | +0.53% since 06/30/26 | +1.47% since 06/30/26 | +7.61% since 06/30/26 | +4.49% since 06/30/26 |
| Low | 2.39 on 12/30/20 | 183.49 on 07/01/26 | 357.89 on 07/01/26 | 125.13 on 07/01/26 | 494.80 on 07/01/26 |
| High | 2.84 on 12/29/20 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.64 on 07/08/26 | 533.67 on 07/07/26 |
| 1-Month | |||||
| %Chg | -2.37% since 11/30/20 | +5.00% since 06/08/26 | +6.28% since 06/08/26 | +6.14% since 06/08/26 | +17.18% since 06/08/26 |
| Low | 2.39 on 12/30/20 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 121.39 on 06/10/26 | 433.80 on 06/10/26 |
| High | 2.84 on 12/29/20 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.64 on 07/08/26 | 533.67 on 07/07/26 |
| 3-Month | |||||
| %Chg | -21.59% since 09/30/20 | -6.68% since 04/08/26 | +5.04% since 04/08/26 | -3.94% since 04/08/26 | +16.92% since 04/08/26 |
| Low | 2.09 on 11/02/20 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 3.24 on 10/01/20 | 207.30 on 04/10/26 | 375.25 on 07/07/26 | 142.97 on 04/09/26 | 533.67 on 07/07/26 |
| 6-Month | |||||
| %Chg | -15.12% since 06/30/20 | +1.38% since 01/08/26 | +11.31% since 01/08/26 | +12.67% since 01/08/26 | +10.51% since 01/08/26 |
| Low | 2.09 on 11/02/20 | 173.65 on 06/18/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 412.27 on 05/05/26 |
| High | 3.78 on 08/19/20 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 533.67 on 07/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,141 | 299,511,328 | 198,666,528 | 169,300,480 | 132,549,664 |
| Shares Outstanding, K | 114,227 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 54,760,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -70,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 4,120,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | 4,400,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.11 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 12/31/21 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | 0.050 on 06/02/16 | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | 09/21/20 | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.54 | 16.58 | 15.49 | 31.49 |